Loring Wolcott & Coolidge Fiduciary Advisors’s Sangamo Therapeutics SGMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-5,000	Closed	-$47K	–	796
2020 Q3	$47K	Hold	5,000	–	–	﹤0.01%	405
2020 Q2	$45K	Hold	5,000	–	–	﹤0.01%	386
2020 Q1	$32K	Hold	5,000	–	–	﹤0.01%	416
2019 Q4	$42K	Buy	+5,000	New	+$42K	﹤0.01%	435